Michael C. Kaufmann to Become CFO of Cardinal Health; Jon Giacomin to Lead Pharmaceutical Segment
Cardinal Health has announced that Michael C. Kaufmann, 51, has been named Chief Financial Officer of the company effective 11 November 2014. This follows the previously announced planned retirement of current Chief Financial Officer Jeffrey W. Henderson, 49. Jon Giacomin, 49, has been named to the role of Chief Executive Officer of the pharmaceutical segment, currently held by Mike Kaufmann, also effective 11 November 2014.
"During the past 24 years, Mike has demonstrated a track record of high performance across many roles for Cardinal Health. His unique blend of financial acumen and extensive operational experience make him ideally suited to take the position of CFO," said George Barrett, Chairman and CEO of Cardinal Health. "We are excited to work with Mike in this new capacity. I'm thrilled that this move also allows us to bring Jon Giacomin into the pharmaceutical segment leadership role. We are privileged to have the opportunity to draw from the deep well of our internal talent."
Kaufmann has served in the role of CEO of Cardinal Health's pharmaceutical segment since 2009. He joined Cardinal Health in 1990 and held a number of senior operational, sales and finance positions. These positions included group president of the medical business of the former healthcare supply chain segment, after serving as the segment's CFO. Prior to joining Cardinal Health, Kaufmann had a successful career in audit and consulting with Arthur Andersen, formerly one of the nation's largest public accounting firms.
Kaufmann is a member of the executive committee of the boards of the Healthcare Distribution Management Association and the National Association of Chain Drug Stores, and a trustee at Ohio Northern University. Kaufmann is the executive sponsor of the Cardinal Health Women's Initiative Network Employee Resource Group, which is dedicated to fostering partnerships that create a great place for women to work and grow their careers, while building a sustainable competitive advantage for Cardinal Health.
To ensure a seamless transition, current Cardinal Health CFO Jeff Henderson will remain as an employee until his retirement just past the end of the fiscal year in August 2015. He will continue to have oversight for Cardinal Health China, in addition to working with the Cardinal Health leadership team on significant initiatives.
Jon Giacomin to Lead Pharmaceutical Segment
A 12-year veteran of Cardinal Health, Giacomin currently serves as president of US Pharmaceutical Distribution. Prior to this, he was Executive Vice President of Pharmaceutical Operations, where he was responsible for warehouse operations at 22 distribution centers and pharmaceutical packaging operations. Giacomin joined Cardinal Health in the pharmaceutical packaging business and served as its Vice President and General Manager before moving to the position of Senior Vice President of inventory management for the former Healthcare Supply Chain Services segment.
Prior to joining Cardinal Health, Giacomin held engineering and operating roles for Griffith Micro Science and Sterigenics. He also served as a lieutenant in the US nuclear Navy, where he held an engineering role.
He currently serves on the boards of trustees of the National Association of Chain Drug Stores Foundation and the Cardinal Health Foundation and as the executive sponsor of the Cardinal Health Veterans and Military Advocates Employee Resource Group.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance